JP2009506113A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009506113A5 JP2009506113A5 JP2008529107A JP2008529107A JP2009506113A5 JP 2009506113 A5 JP2009506113 A5 JP 2009506113A5 JP 2008529107 A JP2008529107 A JP 2008529107A JP 2008529107 A JP2008529107 A JP 2008529107A JP 2009506113 A5 JP2009506113 A5 JP 2009506113A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- formula
- pharmaceutical composition
- carbon atoms
- hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 20
- 239000008194 pharmaceutical composition Substances 0.000 claims 11
- 125000004432 carbon atom Chemical group C* 0.000 claims 9
- 239000001257 hydrogen Substances 0.000 claims 8
- 229910052760 oxygen Inorganic materials 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 229910052727 yttrium Inorganic materials 0.000 claims 5
- 230000032050 esterification Effects 0.000 claims 4
- 238000005886 esterification reaction Methods 0.000 claims 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 125000001931 aliphatic group Chemical group 0.000 claims 3
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 claims 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 3
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 125000000565 sulfonamide group Chemical group 0.000 claims 3
- 230000000694 effects Effects 0.000 claims 2
- 230000004112 neuroprotection Effects 0.000 claims 2
- 239000000018 receptor agonist Substances 0.000 claims 2
- 229940044601 receptor agonist Drugs 0.000 claims 2
- 206010030043 Ocular hypertension Diseases 0.000 claims 1
- 150000002431 hydrogen Chemical group 0.000 claims 1
- 230000004410 intraocular pressure Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71258605P | 2005-08-29 | 2005-08-29 | |
| US11/472,145 US7696235B2 (en) | 2005-08-29 | 2006-06-21 | EP2 receptor agonists for treating glaucoma |
| PCT/US2006/032670 WO2007027468A1 (en) | 2005-08-29 | 2006-08-21 | Ep2 receptor agonists for treating glaucoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009506113A JP2009506113A (ja) | 2009-02-12 |
| JP2009506113A5 true JP2009506113A5 (cg-RX-API-DMAC7.html) | 2009-08-20 |
Family
ID=37529305
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008529107A Pending JP2009506113A (ja) | 2005-08-29 | 2006-08-21 | 緑内障治療のためのｅｐ２レセプターアゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7696235B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1919870A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2009506113A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2006285177A1 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0615245A2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2602442A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2007027468A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2659184C (en) * | 2006-07-28 | 2012-02-21 | Pfizer Products Inc. | Ep2 agonists |
| US8063240B2 (en) | 2007-11-14 | 2011-11-22 | Cayman Chemical Company, Incorporated | Prostaglandin E1 and E2 analogs for the treatment of various medical conditions |
| US8648097B2 (en) * | 2008-03-12 | 2014-02-11 | Ube Industries, Ltd. | Pyridylaminoacetic acid compound |
| ES2564010T3 (es) | 2009-03-30 | 2016-03-17 | Ube Industries, Ltd. | Composición farmacéutica para tratar o prevenir el glaucoma |
| AU2010293410A1 (en) * | 2009-09-11 | 2012-05-03 | Ube Industries, Ltd. | Substituted carbonyl compounds |
| JPWO2011030864A1 (ja) * | 2009-09-11 | 2013-02-07 | 宇部興産株式会社 | アニリン化合物 |
| WO2011030871A1 (ja) * | 2009-09-11 | 2011-03-17 | 宇部興産株式会社 | Ｎ－置換ヘテロアリール化合物 |
| CN109072186B (zh) | 2016-03-04 | 2023-06-23 | 莱兰斯坦福初级大学评议会 | 利用前列腺素e2进行肌肉再生的组合物和方法 |
| KR102698911B1 (ko) | 2017-06-09 | 2024-08-23 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 근육 질환을 예방하거나 치료하기 위한 조성물 및 방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA67754C2 (uk) * | 1997-10-10 | 2004-07-15 | Пфайзер, Інк. | Агоністи простагландину, фармацевтична композиція на їх основі (варіанти), спосіб нарощення та збереження кісткової маси у хребетних та спосіб лікування (варіанти) |
| US20020161026A1 (en) * | 2000-11-07 | 2002-10-31 | Paralkar Vishwas M. | Combination therapies for the stimulation of bone growth |
| EP1601351A1 (en) | 2003-03-04 | 2005-12-07 | Pfizer Products Inc. | Use of ep2 selective receptor agonists in medical treatment |
| WO2005027931A1 (en) * | 2003-09-19 | 2005-03-31 | Pfizer Products Inc. | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an ep2 or ep4 selective agonist |
-
2006
- 2006-06-21 US US11/472,145 patent/US7696235B2/en not_active Expired - Fee Related
- 2006-08-21 CA CA002602442A patent/CA2602442A1/en not_active Abandoned
- 2006-08-21 EP EP06813615A patent/EP1919870A1/en not_active Withdrawn
- 2006-08-21 JP JP2008529107A patent/JP2009506113A/ja active Pending
- 2006-08-21 WO PCT/US2006/032670 patent/WO2007027468A1/en not_active Ceased
- 2006-08-21 AU AU2006285177A patent/AU2006285177A1/en not_active Abandoned
- 2006-08-21 BR BRPI0615245-7A patent/BRPI0615245A2/pt not_active IP Right Cessation